ABUS vs AMZN: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Amazon Com Inc in 2026
ABUS
Arbutus Biopharma Corp
$4.21
AMZN
Amazon Com Inc
$231.00
Key Metrics Comparison
| Metric | ABUS | AMZN | Winner |
|---|---|---|---|
| Market Cap | $780.84M | $2.47T | AMZN |
| P/E Ratio | N/A | 32.67 | AMZN |
| EPS (TTM) | $N/A | $7.07 | AMZN |
| Revenue Growth | -0.6% | 0.1% | AMZN |
| Gross Margin | -98.9% | 50.0% | AMZN |
Analyze ABUS
Full quant analysis
Analyze AMZN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or AMZN a better investment?
Comparing ABUS and AMZN: Arbutus Biopharma Corp has a market cap of $780.84M while Amazon Com Inc has $2.47T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and AMZN?
ABUS (Arbutus Biopharma Corp) and AMZN (Amazon Com Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or AMZN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABUS or AMZN?
AMZN has higher revenue growth at 0.1% vs -0.6% for ABUS.
Which company is more profitable: ABUS or AMZN?
Amazon Com Inc (AMZN) has higher gross margins at 50.0% compared to -98.9% for ABUS.
Which is the larger company: ABUS or AMZN?
Amazon Com Inc (AMZN) is larger with a market cap of $2.47T compared to $780.84M for ABUS.
Should I buy ABUS or AMZN in 2026?
Both ABUS and AMZN have investment merit. ABUS trades at $4.21 while AMZN trades at $231.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and AMZN stock?
Key differences: Market Cap ($780.84M vs $2.47T), P/E Ratio (N/A vs 32.7x), Revenue Growth (-0.6% vs 0.1%), Gross Margin (-98.9% vs 50.0%).